Low-Protein Infant Formula Enriched with Alpha-Lactalbumin during Early Infancy May Reduce Insulin Resistance at 12 Months: A Follow-Up of a Randomized Controlled Trial
Nutrients · 2024
DOI: 10.3390/nu16071026 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2024. Verfasst von Ulrika Tinghäll Nilsson und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences Malmö, Pediatrics, Lund University, 221 00 Lund, Sweden. Hauptthemen laut MEDLINE: Infant Formula, Insulin Resistance. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Arla Foods Ingredients Group P/S, Arla Foods Ingredients, Group P/S, Viby J, Denmark.
Abstract (Originalsprache)
High protein intake during infancy results in accelerated early weight gain and potentially later obesity. The aim of this follow-up study at 12 months was to evaluate if modified low-protein formulas fed during early infancy have long-term effects on growth and metabolism. In a double-blinded RCT, the ALFoNS study, 245 healthy-term infants received low-protein formulas with either alpha-lactalbumin-enriched whey (α-lac-EW; 1.75 g protein/100 kcal), casein glycomacropeptide-reduced whey (CGMP-RW; 1.76 g protein/100 kcal), or standard infant formula (SF; 2.2 g protein/100 kcal) between 2 and 6 months of age. Breastfed (BF) infants served as a reference. At 12 months, anthropometrics and dietary intake were assessed, and serum was analyzed for insulin, C-peptide, and insulin-like growth factor 1 (IGF-1). Weight gain between 6 and 12 months and BMI at 12 months were higher in the SF than in the BF infants (p = 0.019; p < 0.001, respectively), but were not significantly different between the low-protein formula groups and the BF group. S-insulin and C-peptide were higher in the SF than in the BF group (p < 0.001; p = 0.003, respectively), but more alike in the low-protein formula groups and the BF group. Serum IGF-1 at 12 months was similar in all study groups. Conclusion: Feeding modified low-protein formula during early infancy seems to reduce insulin resistance, resulting in more similar growth, serum insulin, and C-peptide concentrations to BF infants at 6-months post intervention. Feeding modified low-protein formula during early infancy results in more similar growth, serum insulin, and C-peptide concentrations to BF infants 6-months post intervention, probably due to reduced insulin resistance in the low-protein groups.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Sciences Malmö, Pediatrics, Lund University, 221 00 Lund, Sweden.
- Department of Nutrition, University of California, Davis, CA 95616, USA.
- Department of Clinical Sciences, Pediatrics, Umeå University, 901 87 Umeå, Sweden.
- Arla Foods Ingredients Group P/S, 8260 Viby, Denmark.
ORCID-Profile: Bo Lönnerdal, Olle Hernell
Förderung
- Arla Foods Ingredients Group P/S
- Arla Foods Ingredients, Group P/S, Viby J, Denmark
Zitieren
APA
Tinghäll Nilsson, U., Lönnerdal, B., Hernell, O., Kvistgaard, A. S., Jacobsen, L. N., & Karlsland Åkeson, P. (2024). Low-Protein Infant Formula Enriched with Alpha-Lactalbumin during Early Infancy May Reduce Insulin Resistance at 12 Months: A Follow-Up of a Randomized Controlled Trial. Nutrients. https://doi.org/10.3390/nu16071026
Vancouver
Tinghäll Nilsson U, Lönnerdal B, Hernell O, Kvistgaard AS, Jacobsen LN, Karlsland Åkeson P. Low-Protein Infant Formula Enriched with Alpha-Lactalbumin during Early Infancy May Reduce Insulin Resistance at 12 Months: A Follow-Up of a Randomized Controlled Trial. Nutrients. 2024. doi:10.3390/nu16071026
BibTeX
@article{TinghllNilsson2024,
author = {Tinghäll Nilsson, Ulrika and Lönnerdal, Bo and Hernell, Olle and Kvistgaard, Anne Staudt and Jacobsen, Lotte Neergaard and Karlsland Åkeson, Pia},
title = {Low-Protein Infant Formula Enriched with Alpha-Lactalbumin during Early Infancy May Reduce Insulin Resistance at 12 Months: A Follow-Up of a Randomized Controlled Trial},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16071026}
}
EUVIMED